Similar articles

• [Myositis associated with tumors].

  András C, Ponyi A, Constantin T, Csiki Z, Illés A, Szegedi G, Dankó K. András C, et al. Magy Onkol. 2002;46(3):253-9. Epub 2002 Oct 6. Magy Onkol. 2002. PMID: 12368921 Hungarian.
• [Dermatomyositis associated with malignant neoplasms].

  Uono M. Uono M. Naika. 1965 Nov;16(6):1062-6. Naika. 1965. PMID: 5887583 Japanese. No abstract available.
• [Dermatomyositis and head and neck neoplasia].

  Mesía R, Solá C, Brunet J, Mendoza L, Sancho G, López Pousa A, Andrés L. Mesía R, et al. Rev Clin Esp. 1995 Jan;195(1):26-8. Rev Clin Esp. 1995. PMID: 7878263 Review. Spanish.
• Clinical and biological factors predictive of malignancy in dermatomyositis.

  Prohic A, Kasumagic-Halilovic E, Simic D, Selmanagic A. Prohic A, et al. J Eur Acad Dermatol Venereol. 2009 May;23(5):591-2. doi: 10.1111/j.1468-3083.2008.02971.x. Epub 2008 Aug 22. J Eur Acad Dermatol Venereol. 2009. PMID: 18752541 No abstract available.
• [Prognostic factors and predictive signs of malignancy in adult dermatomyositis].

  Gallais V, Crickx B, Belaich S. Gallais V, et al. Ann Dermatol Venereol. 1996;123(11):722-6. Ann Dermatol Venereol. 1996. PMID: 9636749 Review. French.